The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis

Nutritional Neuroscience

Volumn 18, Issue 3, 2015, Pages 125-136

  Hadgkiss, Emily J ^a   Jelinek, George A ^a,b   Weiland, Tracey J ^a,c   Pereira, Naresh G ^d   Marck, Claudia H ^a   van der Meer, Dania M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

Diet; Disability; Multiple sclerosis; Quality of life; Relapse

Indexed keywords

ADULT; ARTICLE; CEREAL; DAIRY PRODUCT; DIET; DIET HABITS QUESTIONNAIRE; DIETARY INTAKE; DISABILITY; DISEASE ACTIVITY; EDUCATION; FEMALE; FRUIT; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS QUALITY OF LIFE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELAPSE; VEGETABLE; CHRONIC DISEASE; COMPLICATION; DISEASE COURSE; FEEDING BEHAVIOR; HEALTH STATUS; INTERNATIONAL COOPERATION; LIFESTYLE; MIDDLE AGED; PSYCHOLOGY; RECURRENT DISEASE; RISK FACTOR;

ADULT; CHRONIC DISEASE; DIET; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; FOOD HABITS; HEALTH STATUS; HUMANS; INTERNATIONALITY; LIFE STYLE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUALITY OF LIFE; RECURRENCE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84925190767     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830514Y.0000000117     Document Type: Article

References (52)

1. van der Mei IA, Simpson S, Stankovich J, Taylor BV. Individual and joint action of environmental factors and risk of MS. Neurol Clin 2011; 29: 233-55.
2. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007; 61: 504-13.
3. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-9.
4. Marrie RA. Demographic, genetic, and environmental factors that modify disease course. Neurol Clin 2011; 29: 323-41.
5. Multiple Sclerosis International Federation. Atlas of multiple sclerosis database. London: MSIF, 2013 [updated 2013 Oct; cited 2013 Oct 22]. Available from: http: //www. atlasofms. org/index. aspx.
6. Swank RL, Lerstad O, Strom A, Backer J. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. New Engl J Med 1952; 246: 722-8.
7. Alter M, Yamour M. Multiple sclerosis prevalence and nutritional factors. Trans Am Neurol Assoc 1973; 98: 253-4.
8. Agranoff BW, Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet 1974; 2: 1061-6.
9. Esparza ML, Sasaki S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol 1995; 142: 733-7.
10. Ghadirian P, Jain M, Ducic S, Shatenstein B, Morisset R. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 1998; 27: 845-52.
11. Lauer K. The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor-analytic study. J Clin Epidemiol 1994; 47: 43-8.
12. Gusev E, Boiko A, Lauer K, Riise T, Deomina T. Environmental risk factors in MS: a case-control study in Moscow. Acta Neurol Scand 1996; 94: 386-94.
13. Zhang SM, Willett WC, Hernan MA, Olek MJ, Ascherio A. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 2000; 152: 1056-64.
14. Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990; 336: 37-9.
15. Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, Gallagher E, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 397-404.
16. Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, et al. Vascular comorbidity is associatedwithmore rapid disability progression in multiple sclerosis. Neurology 2010; 74: 1041-7.
17. Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 2011; 8: 127.
18. Weinstock-Guttman B, Zivadinov R, Horakova D, Havrdova E, Qu J, Shyh G, et al. Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry 2013; 84: 1186-91.
19. Corthals AP. Multiple sclerosis is not a disease of the immune system. Q Rev Biol 2011; 86: 287-321.
20. Kennel De March A, De Bouwerie M, Kolopp-Sarda MN, Faure GC, Bene MC, Bernard CC. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. J Neuroimmunol 2003; 135: 117-25.
21. Guggenmos J, Schubart AS, Ogg S, Andersson M, Olsson T, Mather IH. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J Immunol 2004; 172: 661-8.
22. Stefferl A, Schubart A, Storch M, Amini A, Mather I, Lassmann H, et al. Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J Immunol 2000; 165: 2859-65.
23. Malosse D, Perron H, Sasco A, Seigneurin JM. Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study. Neuroepidemiology 1992; 11: 304-12.
24. Malosse D, Perron H. Correlation analysis between bovine populations, other farm animals, house pets, and multiple sclerosis prevalence. Neuroepidemiology 1993; 12: 15-27.
25. Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 2004; 251: 261-8.
26. Zhang SM, Hernan MA, Olek MJ, Spiegelman D, Willett WC, Ascherio A. Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women. Neurology 2001; 57: 75-80.
27. Manouchehrinia A, Constantinescu CS. Cost-effectiveness of disease-modifying therapies in multiple sclerosis. Curr Neurol Neurosci Rep 2012; 12: 592-600.
28. Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev 2012; 12: CD004192.
29. Schwarz S, Knorr C, Geiger H, Flachenecker P. Complementary and alternative medicine for multiple sclerosis. Mult Scler 2008; 14: 1113-9.
30. Leong EM, Semple SJ, Angley M, Siebert W, Petkov J, McKinnon RA. Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why? Complement Ther Med 2009; 17: 216-23.
31. Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, van der Meer DM. Methodology of an international study of people with multiple sclerosis recruited through web 2.0 platforms: demographics, lifestyle, and disease characteristics. Neurol Res Int 2013; 2013: 580596.
32. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4: 187-206.
33. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology 1995; 45: 251-5.
34. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 1999; 5: 349.
35. Learmonth YC, Motl RW, Sandroff BM, Pula JH, Cadavid D. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol 2013; 13: 37.
36. McKellar S, Horsley P, Chambers R, Pullen M, Vandersee P, Clarke C, et al. Development of the Diet Habits Questionnaire for use in cardiac rehabilitation. Aust J Prim Health 2008; 14: 43-7.
37. Dobson AJ, Blijlevens R, Alexander HM, Croce N, Heller RF, Higginbotham N, et al. Short fat questionnaire: a self-administered measure of fat-intake behaviour. Aust J Pub Health 1993; 17: 144-9.
38. Wright JL, Scott JA. The fat and fibre barometer, a short food behaviour questionnaire: reliability, relative validity and utility. Aust J Nutr Diet 2000; 57: 33-9.
39. Jelinek GA, Hadgkiss EJ, Weiland TJ, Pereira NG, Marck CH, van der Meer DM. Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis. Int J Neurosci 2013; 123: 792-801.
40. Weiland TJ, Hadgkiss EJ, Jelinek GA, Pereira NG, Marck CH, van der Meer DM. The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. J Neurol Sci 2014; 336: 211-9.
41. Kappos L, Gold R, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, et al. Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study. Mult Scler 2014; 20: 243-52.
42. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-92.
43. Riccio P, Rossano R, Liuzzi GM. May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. Autoimmune Dis 2011; 2010: 249842.
44. Das UN. Is there a role for saturated and long-chain fatty acids in multiple sclerosis? Nutrition 2003; 19: 163-6.
45. Schwarz S, Leweling H. Multiple sclerosis and nutrition. Mult Scler 2005; 11: 24-32.
46. Swank RL, Goodwin JW. How saturated fats may be a causative factor in multiple sclerosis and other diseases. Nutrition 2003; 19: 478.
47. Valerio M, Liu HB, Heffner R, Zivadinov R, Ramanathan M, Weinstock-Guttman B, et al. Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis. Inflamm Res 2011; 60: 457-65.
48. Desai F, Ramanathan M, Fink CS, Wilding GE, Weinstock-Guttman B, Awad AB. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients. Int Immunopharmacol 2009; 9: 153-7.
49. von Geldern G, Mowry EM. The influence of nutritional factors on the prognosis of multiple sclerosis. Nat Rev Neurol 2012; 8: 678-89.
50. Rosell M, Appleby P, Spencer E, Key T. Weight gain over 5 years in 21, 966 meat-eating, fish-eating, vegetarian, and vegan men and women in EPIC-Oxford. Int J Obes (Lond) 2006; 30: 1389-96.
51. Appleby PN, Davey GK, Key TJ. Hypertension and blood pressure among meat eaters, fish eaters, vegetarians and vegans in EPIC-Oxford. Public Health Nutr 2002; 5: 645-54.
52. Coulston AM, Boushey CJ, Ferruzzi MG. Dietary assessment methodology. Nutrition in the prevention and treatment of disease. San Diego: Academic Press; 2013, chapter 1.